Real-time enrollment status for this hematologic neoplasms clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 7:15 PM UTC
| NCT Number | NCT07572006 |
| Recruiting Status | Recruiting |
| Condition | Hematologic Neoplasms |
| Phase | PHASE1 |
| Target Enrollment | 360 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Janssen Research & Development, LLC |
| Last Updated on CT.gov | August 28, 2026 (2 days ago) |
As of August 30, 2026: Clinical trial NCT07572006 is currently recruiting participants. This phase1 study for hematologic neoplasms is actively seeking new participants at 6 locations across the United States. The study is sponsored by Janssen Research & Development, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07572006 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07572006 was last updated 2 days ago (August 28, 2026). HelloStudys verifies this status automatically.